Superworth

Lyell Immunopharma market cap LYEL

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$266.6M
Highest close in our data
$4.3B
Sep 2021

Lyell Immunopharma is worth $266.6M at the close on Nov 2, 2026, at $10.88 a share.

That is down 21% over the last year and down 92% over five years.

Its highest close in our data was $4.3B in Sep 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$266.6M$199M$614.9M−64%
2025$744.5M$118.1M$744.5M+310%
2024$181.5M$171M$780.1M−63%
2023$488.6M$359M$873.6M−44%
2022$865.2M$760.4M$1.9B−54%
2021$1.9B$1.9B$4.3Bn/a

Against its peers

Companies in Drug Manufacturers - General nearest Lyell Immunopharma's size, closest first, today.

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Lyell Immunopharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.